• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Acute pro-B-cell lymphoblastic leukemia evolving from myelodysplastic neoplasm post cytotoxic therapy: a case report.

作者信息

Wobst Jana, Truger Marietta, Baer Constance, Meggendorfer Manja, Kern Wolfgang, Haferlach Torsten, Haferlach Claudia

机构信息

MLL Munich Leukemia Laboratory, Munich.

出版信息

Haematologica. 2025 Aug 1;110(8):1894-1897. doi: 10.3324/haematol.2025.287357. Epub 2025 Apr 10.

DOI:10.3324/haematol.2025.287357
PMID:40207709
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12358784/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8d6/12358784/cb4943aa6770/1101894.fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8d6/12358784/bd02079bbaae/1101894.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8d6/12358784/697c43f52875/1101894.fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8d6/12358784/cb4943aa6770/1101894.fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8d6/12358784/bd02079bbaae/1101894.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8d6/12358784/697c43f52875/1101894.fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8d6/12358784/cb4943aa6770/1101894.fig3.jpg

相似文献

1
Acute pro-B-cell lymphoblastic leukemia evolving from myelodysplastic neoplasm post cytotoxic therapy: a case report.细胞毒性治疗后由骨髓增生异常肿瘤演变而来的急性前体B细胞淋巴细胞白血病：一例报告
Haematologica. 2025 Aug 1;110(8):1894-1897. doi: 10.3324/haematol.2025.287357. Epub 2025 Apr 10.
2
Comment on "Acute pro-B-cell lymphoblastic leukemia evolving from myelodysplastic neoplasm post cytotoxic therapy: a case report".关于“细胞毒性治疗后骨髓增生异常肿瘤演变为急性前体B细胞淋巴细胞白血病：一例报告”的评论
Haematologica. 2025 May 15. doi: 10.3324/haematol.2025.288110.
3
Therapy-related myeloid neoplasm in an 18-year-old boy with B-lymphoblastic leukemia.一名患有B淋巴细胞白血病的18岁男孩的治疗相关髓系肿瘤
Exp Mol Pathol. 2017 Dec;103(3):263-266. doi: 10.1016/j.yexmp.2017.11.007. Epub 2017 Nov 16.
4
A case report of secondary B-cell acute lymphoblastic leukemia treated with a combination of FLT3 inhibitor and decitabine.一例采用FLT3抑制剂与地西他滨联合治疗继发性B细胞急性淋巴细胞白血病的病例报告。
Front Oncol. 2024 Apr 26;14:1329279. doi: 10.3389/fonc.2024.1329279. eCollection 2024.
5
T and NK lymphoblastic leukemia/lymphoma: Report from the 2023 SH/EAHP Workshop.T和NK淋巴细胞白血病/淋巴瘤：2023年SH/EAHP研讨会报告
Am J Clin Pathol. 2025 Jul 11;164(1):26-35. doi: 10.1093/ajcp/aqaf015.
6
[FGFR1-mutated B-cell acute lymphoblastic leukemia transforming to myelodysplastic / myeloproliferative neoplasm and acute myeloid leukemia].[成纤维细胞生长因子受体1（FGFR1）突变的B淋巴细胞急性淋巴细胞白血病转化为骨髓增生异常/骨髓增殖性肿瘤及急性髓系白血病]
Rinsho Ketsueki. 2018;59(7):872-877. doi: 10.11406/rinketsu.59.872.
7
Myelodysplastic syndrome transformed into B-lineage acute lymphoblastic leukemia: A case report.骨髓增生异常综合征转化为B系急性淋巴细胞白血病：一例报告。
World J Clin Cases. 2021 Jul 6;9(19):5191-5196. doi: 10.12998/wjcc.v9.i19.5191.
8
Blinatumomab Therapy Is Associated with Favorable Outcomes after Allogeneic Hematopoietic Cell Transplantation in Pediatric Patients with B Cell Acute Lymphoblastic Leukemia.Blinatumomab 治疗与儿童 B 细胞急性淋巴细胞白血病患者异基因造血细胞移植后的良好结局相关。
Transplant Cell Ther. 2024 Feb;30(2):217-227. doi: 10.1016/j.jtct.2023.10.024. Epub 2023 Nov 4.
9
Lineage Switch Between B-Lymphoblastic Leukemia and Acute Myeloid Leukemia Intermediated by "Occult" Myelodysplastic Neoplasm: Two Cases of Adult Patients With Evidence of Genomic Instability and Clonal Selection by Chemotherapy.“隐匿性”骨髓增生异常肿瘤介导的B淋巴细胞白血病与急性髓系白血病之间的谱系转换：两例有基因组不稳定证据及化疗克隆选择的成年患者
Am J Clin Pathol. 2017 Aug 1;148(2):136-147. doi: 10.1093/ajcp/aqx055.
10
B-cell acute lymphoblastic leukemia as a secondary malignancy following diffuse large B-cell lymphoma.弥漫性大B细胞淋巴瘤继发的B细胞急性淋巴细胞白血病
Hematol Rep. 2019 Jun 14;11(2):8100. doi: 10.4081/hr.2019.8100. eCollection 2019 May 23.

本文引用的文献

1
Acute lymphoblastic leukemia in patients treated with lenalidomide for multiple myeloma: a safety meta-analysis of randomized controlled trials combined with a retrospective study of the WHO's pharmacovigilance database.来那度胺治疗多发性骨髓瘤患者时发生的急性淋巴细胞白血病：随机对照试验的安全性荟萃分析及结合世界卫生组织药物警戒数据库的回顾性研究
Blood Cancer J. 2024 Oct 14;14(1):177. doi: 10.1038/s41408-024-01154-z.
2
Acute Lymphoblastic Leukemia with Myeloid Mutations Is a High-Risk Disease Associated with Clonal Hematopoiesis.伴有髓系突变的急性淋巴细胞白血病是一种与克隆性造血相关的高危疾病。
Blood Cancer Discov. 2024 May 1;5(3):164-179. doi: 10.1158/2643-3230.BCD-23-0106.
3
Prediction of risk for myeloid malignancy in clonal hematopoiesis.
克隆性造血中髓系恶性肿瘤风险的预测
NEJM Evid. 2023 May;2(5). doi: 10.1056/evidoa2200310. Epub 2023 Apr 25.
4
Lenalidomide-associated B-cell ALL: clinical and pathologic correlates and sensitivity to lenalidomide withdrawal.来那度胺相关的 B 细胞 ALL：临床和病理相关性以及对来那度胺停药的敏感性。
Blood Adv. 2023 Jul 11;7(13):3087-3098. doi: 10.1182/bloodadvances.2022009212.
5
Second primary malignancies in patients with haematological cancers treated with lenalidomide: a systematic review and meta-analysis.接受来那度胺治疗的血液系统恶性肿瘤患者的第二原发性恶性肿瘤：系统评价和荟萃分析。
Lancet Haematol. 2022 Dec;9(12):e906-e918. doi: 10.1016/S2352-3026(22)00289-7. Epub 2022 Oct 27.
6
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data.国际髓系肿瘤和急性白血病分类：整合形态学、临床和基因组数据。
Blood. 2022 Sep 15;140(11):1200-1228. doi: 10.1182/blood.2022015850.
7
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.世界卫生组织血液淋巴肿瘤分类第五版：髓系和组织细胞/树突状肿瘤。
Leukemia. 2022 Jul;36(7):1703-1719. doi: 10.1038/s41375-022-01613-1. Epub 2022 Jun 22.
8
What's new in the pathogenesis and treatment of therapy-related myeloid neoplasms.治疗相关髓系肿瘤发病机制和治疗的新进展。
Blood. 2021 Sep 2;138(9):749-757. doi: 10.1182/blood.2021010764.
9
Genetics of progression from MDS to secondary leukemia.MDS 向继发性白血病进展的遗传学研究。
Blood. 2020 Jul 2;136(1):50-60. doi: 10.1182/blood.2019000942.
10
Therapy-related acute lymphoblastic leukemia is a distinct entity with adverse genetic features and clinical outcomes.治疗相关性急性淋巴细胞白血病是一种具有不良遗传学特征和临床结局的独特实体。
Blood Adv. 2019 Dec 23;3(24):4228-4237. doi: 10.1182/bloodadvances.2019000925.